요약정보
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.
- Resource Type
- Academic Journal
- Authors
- Vijai J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Topka S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Villano D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Ravichandran V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Maxwell KN; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.; Maria A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Thomas T; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Gaddam P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering, New York, New York.; Lincoln A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering, New York, New York.; Kazzaz S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Wenz B; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.; Carmi S; Braun School of Public Health and Community Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Schrader KA; British Columbia Cancer Agency, Canada's Michael Smith Genome Sciences Centre, Vancouver, Canada.; Hart SN; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.; Lipkin SM; Department of Medicine, Weill Cornell Medical College, New York, New York.; Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California.; Walsh MF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering, New York, New York.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.; Zhang L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.; Lejbkowicz F; Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B Rappaport Faculty of Medicine, Haifa, Israel.; Rennert H; Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B Rappaport Faculty of Medicine, Haifa, Israel.; Stadler ZK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.; Robson M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.; Weitzel JN; Clinical Cancer Genetics (for the City of Hope Clinical Cancer Genetics Community Research Network), City of Hope, Duarte, California.; Domchek S; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.; Daly MJ; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts.; Center for Human Genetic Research and Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Couch FJ; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.; Department of Laboratory Medicine and Pathology, and Health Sciences Research, Mayo Clinic, Rochester, Minnesota.; Nathanson KL; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.; Norton L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Rennert G; Clalit National Israeli Cancer Control Center and Department of Community Medicine and Epidemiology, Carmel Medical Center and B Rappaport Faculty of Medicine, Haifa, Israel.; Offit K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. offitk@mskcc.org.; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.
- Source
- Publisher:
American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN:21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE - Subject
- Language
- English